Drugs / MTX
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT03885388 Comparator | Mar 2019 → Dec 2021 | chemotherapy-induced toxicity, gestational trophoblastic neoplasm | Women's Hospital School Of Medicine Zhejiang University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03885388 ↗ |
| Route | Intramuscular | “intramuscular” NCT03885388 ↗ |